These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

153 related articles for article (PubMed ID: 12043079)

  • 21. Fanconi syndrome and renal failure induced by tenofovir: a first case report.
    Verhelst D; Monge M; Meynard JL; Fouqueray B; Mougenot B; Girard PM; Ronco P; Rossert J
    Am J Kidney Dis; 2002 Dec; 40(6):1331-3. PubMed ID: 12460055
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Tenofovir: FDA hearing on important new antiretroviral.
    James JS
    AIDS Treat News; 2001 Oct; (372):2-4. PubMed ID: 11702411
    [No Abstract]   [Full Text] [Related]  

  • 23. [Resistance in a new light. About mutations and their interactions].
    MMW Fortschr Med; 2003 Apr; 145 Spec No 1():64-5. PubMed ID: 15011595
    [No Abstract]   [Full Text] [Related]  

  • 24. Tenofovir disoproxil fumarate.
    Kumar A
    Drugs; 2003; 63(15):1609-10. PubMed ID: 12887267
    [No Abstract]   [Full Text] [Related]  

  • 25. New uses for tenofovir: more questions about d4T.
    Proj Inf Perspect; 2003 Jan; (35):15-6. PubMed ID: 12647676
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Tenofovir--long term results from first-line therapy.
    TreatmentUpdate; 2003; 15(2):4-6. PubMed ID: 12693361
    [No Abstract]   [Full Text] [Related]  

  • 27. [First nucleotide analog with noteworthy safety profile. Tenofovir effective in all stages of the infection].
    MMW Fortschr Med; 2003 Apr; 145 Spec No 1():62-4. PubMed ID: 15011594
    [No Abstract]   [Full Text] [Related]  

  • 28. FDA approves Viread for HIV-1 infection.
    FDA Consum; 2002; 36(1):5. PubMed ID: 11881601
    [No Abstract]   [Full Text] [Related]  

  • 29. Tenofovir disoproxil fumarate.
    Antoniou T
    Drugs; 2003; 63(15):1609-10. PubMed ID: 12887266
    [No Abstract]   [Full Text] [Related]  

  • 30. Tenofovir: what have over 1 million years of patient experience taught us?
    Pozniak A
    Int J Clin Pract; 2008 Aug; 62(8):1285-93. PubMed ID: 18705824
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Tenofovir and didanosine: a dangerous liaison.
    Waters L; Maitland D; Moyle GJ
    AIDS Read; 2005 Aug; 15(8):403-6, 413. PubMed ID: 16110555
    [No Abstract]   [Full Text] [Related]  

  • 32. K65R, TAMs and tenofovir.
    Miller MD
    AIDS Rev; 2004; 6(1):22-33. PubMed ID: 15168738
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Pancreatitis with didanosine and tenofovir disoproxil fumarate [corrected].
    Blanchard JN; Wohlfeiler M; Canas A; King K; Lonergan JT
    Clin Infect Dis; 2003 Sep; 37(5):e57-62. PubMed ID: 12942419
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Tenofovir-associated kidney diseases and interactions between tenofovir and other antiretrovirals.
    Lanzafame M; Lattuada E; Rapagna F; Gottardi M; Vento S
    Clin Infect Dis; 2006 Jun; 42(11):1656-7; author reply 1658. PubMed ID: 16652329
    [No Abstract]   [Full Text] [Related]  

  • 35. The role of drug interactions and monitoring in the prevention of tenofovir-associated kidney disease.
    Winston JA; Shepp DH
    Clin Infect Dis; 2006 Jun; 42(11):1657-8; author reply 1658. PubMed ID: 16652330
    [No Abstract]   [Full Text] [Related]  

  • 36. [Once daily administration improves therapy adherence in HAART. New substance class with more powerful reserves against virus resistance].
    MMW Fortschr Med; 2001 Apr; 143 Suppl 1():86-9. PubMed ID: 11373792
    [No Abstract]   [Full Text] [Related]  

  • 37. Nephrolithiasis and hydronephrosis in an HIV-infected man receiving tenofovir.
    Cicconi P; Bongiovanni M; Melzi S; Tordato F; d'Arminio Monforte A; Bini T
    Int J Antimicrob Agents; 2004 Sep; 24(3):284-5. PubMed ID: 15325433
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Tenofovir: Gilead applies for approval; expanded access liberalized.
    Gilden D
    AIDS Treat News; 2001 May; (364):2-3, 1. PubMed ID: 11569959
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Summaries for patients. Treatment for resistant HIV-1 infection.
    Ann Intern Med; 2003 Sep; 139(5 Pt 1):I22. PubMed ID: 12965954
    [No Abstract]   [Full Text] [Related]  

  • 40. Promising results for tenofovir.
    AIDS Patient Care STDS; 2000 Jul; 14(7):396. PubMed ID: 10935058
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.